Verrica Pharmaceuticals (VRCA) Stock: Buy, Sell, or Hold?
VRCA - Verrica Pharmaceuticals Inc. Common Stock
$4.38
-0.13 (-2.99%)
▼
5d:
+0.23%
30d:
-18.74%
90d:
-28.55%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When VRCA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VRCA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: VRCA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: VRCA is currently trading at $4.38, which is considered oversold relative to its 30-day fair value range of $4.48 to $5.22.
Technical Outlook: Technically, VRCA is in a strong downtrend. The price is currently testing key support at $4.32. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: VRCA scores 96/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $13.83 (+215.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VRCA is in a strong downtrend. The price is currently testing key support at $4.32. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: VRCA scores 96/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $13.83 (+215.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.48 -
$5.22
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (96/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 215.8% below Wall St target ($13.83)
- CAUTION: Bottoming setup, but lagging the sector by 32% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$4.48 -
$5.22
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$4.32
Resistance Level
$5.04
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.96
Wall Street Target
$13.83
(+215.8%)
Revenue Growth (YoY)
-53.9%
Profit Margin
-102.8%
Share & Embed Analysis
Last updated: October 03, 2026 3:17 AM ET
Data refreshes hourly during market hours. Next update: 4:17 AM
Data refreshes hourly during market hours. Next update: 4:17 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VRCA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 71 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$75 | 60 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$28 | 53 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 58 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$95 | 57 HOLD |
